BBI-4000
Phase 1Completed 0 watching 0 views this week๐ค Quiet
25
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hyperhidrosis
Conditions
Hyperhidrosis
Trial Timeline
Feb 1, 2014 โ Sep 1, 2014
NCT ID
NCT02058264About BBI-4000
BBI-4000 is a phase 1 stage product being developed by Botanix Pharmaceuticals for Hyperhidrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02058264. Target conditions include Hyperhidrosis.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02058264 | Phase 1 | Completed |
Competing Products
14 competing products in Hyperhidrosis
Other Products from Botanix Pharmaceuticals
Sofpironium Bromide, 15% + VehiclePhase 3
69
Sofpironium Bromide Gel, 15% + VehiclePhase 3
69
Sofpironium Bromide Gel, 5% + Sofpironium Bromide Gel, 15%Phase 3
69
BBI-4000 gel, 5% + BBI-4000 gel, 10% + BBI-4000 gel, 15% + Vehicle (Placebo)Phase 2
44
BBI-4000 Gel, 5% + BBI-4000 Gel, 10% + BBI-4000 Gel, 15% + VehiclePhase 2
44